Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Open source

DOI
10.1111/1759-7714.13622
Published
2020 Oct
Container
Thoracic cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1759-7714.13622,
  title = {Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.},
  author = {Imai H and Minemura H and Kishikawa T and Yamada Y and Suzuki K and Umeda Y and Wasamoto S and Kasahara N and Ishihara S and Yamaguchi O and Naruse I and Uchino J and Mori K and Kanazawa K and Shibata Y and Kasai T and Kaburagi T and Kaira K and Minato K},
  year = {2020},
  journal = {Thoracic cancer},
  doi = {10.1111/1759-7714.13622},
  url = {https://doi.org/10.1111/1759-7714.13622}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
AU  - Imai H
AU  - Minemura H
AU  - Kishikawa T
AU  - Yamada Y
AU  - Suzuki K
AU  - Umeda Y
AU  - Wasamoto S
AU  - Kasahara N
AU  - Ishihara S
AU  - Yamaguchi O
AU  - Naruse I
AU  - Uchino J
AU  - Mori K
AU  - Kanazawa K
AU  - Shibata Y
AU  - Kasai T
AU  - Kaburagi T
AU  - Kaira K
AU  - Minato K
PY  - 2020
JO  - Thoracic cancer
DO  - 10.1111/1759-7714.13622
UR  - https://doi.org/10.1111/1759-7714.13622
ER  - 

APA

H, I., H, M., T, K., Y, Y., K, S., Y, U., S, W., N, K., S, I., O, Y., I, N., J, U., K, M., K, K., Y, S., T, K., T, K., K, K., & K, M. (2020). Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.. Thoracic cancer. https://doi.org/10.1111/1759-7714.13622

Source records